{
  "catalogId": "ae6d4607-9d8a-4c9f-8dae-db52b20b3919",
  "name": "SUNITINIB TEVA  ® 12.5 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "163 78 35252 00",
  "treatmentDescriptions": "Sunitinib Teva is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to Imatinib Mesylate. Sunitinib Teva is indicated for the treatment of advanced renal cell carcinoma. Treatment of unresectable or metastatic,  well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.",
  "termsOfIssue": "Prescription required",
  "form": "capsules",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "SUNITINIB AS BASE 12.5  MG",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XE04",
      "name": "SUNITINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "SUNITINIB TEVA 25 MG 30CAPS",
      "manufacturer": {
        "name": "טבע",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/ACLAR/PVC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8978",
        "yarpa": "74039",
        "pharmasoft": "17531",
        "barcode": "7290106065529"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 3353.457428,
        "retailMargin": 10.0,
        "maxRetailPrice": 3688.803171,
        "maxPriceWithVAT": 4352.787742
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:13.054325"
  }
}